These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2444306)

  • 1. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study.
    Kirby RS; Coppinger SW; Corcoran MO; Chapple CR; Flannigan M; Milroy EJ
    Br J Urol; 1987 Aug; 60(2):136-42. PubMed ID: 2444306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-adrenoceptor inhibitors in the treatment of benign prostatic hyperplasia.
    Kirby RS
    Am J Med; 1989 Aug; 87(2A):26S-30S. PubMed ID: 2475016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prazosin in men with symptoms of bladder neck obstruction and a non-hyperplastic prostate.
    Hedlund H; Andersson KE
    Scand J Urol Nephrol; 1989; 23(4):251-4. PubMed ID: 2480639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week placebo-controlled double-blind study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia.
    Chapple CR; Stott M; Abrams PH; Christmas TJ; Milroy EJ
    Br J Urol; 1992 Sep; 70(3):285-94. PubMed ID: 1384919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction.
    Chapple CR; Carter P; Christmas TJ; Kirby RS; Bryan J; Milroy EJ; Abrams P
    Br J Urol; 1994 Jul; 74(1):50-6. PubMed ID: 7519112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction.
    Chapple CR; Christmas TJ; Milroy EJ
    Urol Int; 1990; 45 Suppl 1():47-55. PubMed ID: 1690482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and side-effects of prazosin as a symptomatic treatment of benign prostatic obstruction.
    Ruutu ML; Hansson E; Juusela HE; Permi JE; Rusk JI; Sotarauta MT; Talja MT; Wuokko EJ; Mattila MJ
    Scand J Urol Nephrol; 1991; 25(1):15-9. PubMed ID: 1710823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoramin in the treatment of prostatic bladder outflow obstruction.
    Stott MA; Abrams P
    Br J Urol; 1991 May; 67(5):499-501. PubMed ID: 1710162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
    Caine M; Perlberg S; Meretyk S
    Br J Urol; 1978 Dec; 50(7):551-4. PubMed ID: 88984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prazosin HCl on micturition disturbance associated with benign prostatic hypertrophy and bladder neck contracture.
    Kohama Y; Watanabe H; Sen Y; Yamamoto Y; Morioka M; Fujita Y
    Urol Int; 1990; 45 Suppl 1():26-9. PubMed ID: 1690477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.
    Witjes WP; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
    Urology; 1997 Feb; 49(2):197-205; discussion 205-6. PubMed ID: 9037281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
    Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
    J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prazosin in patients with benign prostatic obstruction.
    Hedlund H; Andersson KE; Ek A
    J Urol; 1983 Aug; 130(2):275-8. PubMed ID: 6192252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy.
    Le Duc A; Cariou G; Baron C; Cukier J; Quentel P; Faure G; Rambeaud JJ; Navratil H; Costa P; Richaud JJ
    Urol Int; 1990; 45 Suppl 1():56-62. PubMed ID: 1690483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prazosin and carbachol in patients with benign prostatic obstruction.
    Hedlund H; Andersson KE
    Scand J Urol Nephrol; 1988; 22(1):19-22. PubMed ID: 2455331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.
    McNeill SA; Hargreave TB; Geffriaud-Ricouard C; Santoni J; Roehrborn CG
    Urology; 2001 Mar; 57(3):459-65. PubMed ID: 11248620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.
    Ronchi F; Margonato A; Ceccardi R; Rigatti P; Rossini BM
    Urol Res; 1982; 10(3):131-4. PubMed ID: 6182672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia.
    Witjes WP; Rosier FW; de Wildt MJ; van Iersel MP; Debruyne FM; de La Rosette JJ
    J Urol; 1996 Apr; 155(4):1317-23. PubMed ID: 8632523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia.
    Tammela TL; Kontturi MJ
    J Urol; 1993 Feb; 149(2):342-4. PubMed ID: 7678871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.